Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial
Patrick M. O’Neil(Medical University of South Carolina), Andreas L. Birkenfeld(University Hospital Carl Gustav Carus), Barbara McGowan(Guy's and St Thomas' NHS Foundation Trust), Ofri Mosenzon, Sue D. Pedersen(LMC Diabetes & Endocrinology (Canada)), Sean Wharton(York University), Charlotte Giwercman Carson(Novo Nordisk (Denmark)), Cecilie H. Jepsen(Novo Nordisk (Denmark)), Maria Kabisch(Novo Nordisk (Denmark)), John Wilding(University of Liverpool)
Cited by 793
Abstract
Related Papers
No related papers found
Powered by citation graph analysis